Stent procedure eases severe symptoms in cancer patients with blocked veins
NCT ID NCT07252570
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study looked at placing a small metal tube (stent) into the portal vein of 63 cancer patients whose vein was blocked by a tumor. The goal was to relieve serious symptoms like fluid buildup in the belly or bleeding in the gut. The procedure was done through a needle in the liver, and the team checked how long the stent stayed open and how well it worked.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- self-expanding metallic stent
- What this could lead to
- If successful, this procedure could offer a minimally invasive way to relieve severe symptoms like fluid buildup and bleeding in cancer patients with blocked portal veins.
- What could go wrong
- This was a small, retrospective study with only 63 patients, so results may not apply to everyone. The procedure carries risks like bleeding or infection, and the stent may block again over time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BILIARY TRACT NEOPLASMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de NICE
Nice, Alpes Maritimes, 06000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can extra doses of an old drug reverse liver scarring?
- Could a radiofrequency knife beat the stapler for safer pancreas surgery?
- Could the Body's largest vein replace a Hard-to-Reach one for liver pressure checks?
- Could a dissolvable sponge replace medical glue for dangerous stomach vein bleeds?
- New device aims to seal pancreas during robotic surgery, cutting leak risk
- Experimental drug hopes to boost chemo against tough pancreatic cancer